Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 20, 2020
VIVUS
|
Post-IPO Equity | $33.60M | Biopharma | Yes |
Aug 4, 2014
Mevion Medical Systems
|
Private Equity(PE) | $200M | Biotechnology | — |
Jun 25, 2013
Mevion Medical Systems
|
Private Equity(PE) | $55M | Biotechnology | — |
Dec 17, 2012
Regado Biosciences
|
Series E | $51M | Biotechnology | — |
Aug 24, 2010
Gemin X Pharmaceuticals
|
Series E | $8M | Biotechnology | Yes |
Caxton Advantage Life Sciences Fund has had 6 exits. Caxton Advantage Life Sciences Fund most notable exits include Anthera Pharmaceuticals , Regado Biosciences
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 28, 2018 | Anthera Pharmaceuticals | IPO | Biotechnology | Detail |
Aug 22, 2013 | Regado Biosciences | IPO | Biotechnology | Detail |
Mar 21, 2011 | Gemin X Pharmaceuticals | M&A | Biotechnology | Detail |
Dec 23, 2009 | Corthera | M&A | Biotechnology | Detail |
Oct 27, 2005 | Sunesis Pharmaceuticals | M&A | Biotechnology | Detail |